Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 84

1.

New Standards for Negative Symptom Assessment.

Carpenter WT, Blanchard JJ, Kirkpatrick B.

Schizophr Bull. 2016 Jan;42(1):1-3. doi: 10.1093/schbul/sbv160. Epub 2015 Nov 28. No abstract available.

PMID:
26615186
2.

A Major Gene for Bovine Ovulation Rate.

Kirkpatrick BW, Morris CA.

PLoS One. 2015 Jun 5;10(6):e0129025. doi: 10.1371/journal.pone.0129025. eCollection 2015.

3.

Brain white matter microstructure in deficit and non-deficit subtypes of schizophrenia.

Spalletta G, De Rossi P, Piras F, Iorio M, Dacquino C, Scanu F, Girardi P, Caltagirone C, Kirkpatrick B, Chiapponi C.

Psychiatry Res. 2015 Mar 30;231(3):252-61. doi: 10.1016/j.pscychresns.2014.12.006. Epub 2015 Jan 3.

PMID:
25649975
4.

Genome-wide association study of susceptibility to infection by Mycobacterium avium subspecies paratuberculosis in Holstein cattle.

Alpay F, Zare Y, Kamalludin MH, Huang X, Shi X, Shook GE, Collins MT, Kirkpatrick BW.

PLoS One. 2014 Dec 4;9(12):e111704. doi: 10.1371/journal.pone.0111704. eCollection 2014.

5.

Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Ahmed AO, Strauss GP, Buchanan RW, Kirkpatrick B, Carpenter WT.

Schizophr Bull. 2015 Jul;41(4):879-91. doi: 10.1093/schbul/sbu163. Epub 2014 Nov 14.

PMID:
25399026
6.

Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia.

Buckley PF, Miller BJ, Pillai A, Kirkpatrick B.

Schizophr Res. 2014 Sep;158(1-3):268-9. doi: 10.1016/j.schres.2014.06.030. Epub 2014 Jul 19. No abstract available.

PMID:
25052781
7.

Recognizing primary vs secondary negative symptoms and apathy vs expression domains.

Kirkpatrick B.

J Clin Psychiatry. 2014 Apr;75(4):e09. doi: 10.4088/JCP.13049tx3c. Review.

PMID:
24813410
8.

Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.

Kirkpatrick B.

J Clin Psychiatry. 2014;75 Suppl 1:3-7. doi: 10.4088/JCP.13049su1c.01.

PMID:
24581452
9.

Progress in the study of negative symptoms.

Kirkpatrick B.

Schizophr Bull. 2014 Mar;40 Suppl 2:S101-6. doi: 10.1093/schbul/sbt158.

10.

Genome-wide association analysis and genomic prediction of Mycobacterium avium subspecies paratuberculosis infection in US Jersey cattle.

Zare Y, Shook GE, Collins MT, Kirkpatrick BW.

PLoS One. 2014 Feb 11;9(2):e88380. doi: 10.1371/journal.pone.0088380. eCollection 2014.

11.

Defining and measuring negative symptoms of schizophrenia in clinical trials.

Marder SR, Kirkpatrick B.

Eur Neuropsychopharmacol. 2014 May;24(5):737-43. doi: 10.1016/j.euroneuro.2013.10.016. Epub 2013 Nov 11. Review.

PMID:
24275698
12.

Inflammation and schizophrenia.

Kirkpatrick B, Miller BJ.

Schizophr Bull. 2013 Nov;39(6):1174-9. doi: 10.1093/schbul/sbt141. Epub 2013 Sep 26. Review. No abstract available.

13.

Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome.

Galderisi S, Bucci P, Mucci A, Kirkpatrick B, Pini S, Rossi A, Vita A, Maj M.

Schizophr Res. 2013 Jun;147(1):157-62. doi: 10.1016/j.schres.2013.03.020. Epub 2013 Apr 19.

PMID:
23608244
14.

Understanding the physiology of schizophrenia.

Kirkpatrick B.

J Clin Psychiatry. 2013 Mar;74(3):e05. doi: 10.4088/JCP.12045tx3c.

PMID:
23561237
15.

Schizophrenia: a systemic disorder.

Kirkpatrick B, Miller B, García-Rizo C, Fernandez-Egea E.

Clin Schizophr Relat Psychoses. 2014 Jul;8(2):73-9. doi: 10.3371/CSRP.KIMI.031513. Review.

16.

Screening for substance use disorders in first-episode psychosis: implications for readmission.

Batalla A, Garcia-Rizo C, Castellví P, Fernandez-Egea E, Yücel M, Parellada E, Kirkpatrick B, Martin-Santos R, Bernardo M.

Schizophr Res. 2013 May;146(1-3):125-31. doi: 10.1016/j.schres.2013.02.031. Epub 2013 Mar 19.

17.

Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT Jr.

J Psychiatr Res. 2013 Jun;47(6):783-90. doi: 10.1016/j.jpsychires.2013.01.015. Epub 2013 Feb 27.

18.

Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression.

Garcia-Rizo C, Fernandez-Egea E, Miller BJ, Oliveira C, Justicia A, Griffith JK, Heaphy CM, Bernardo M, Kirkpatrick B.

Brain Behav Immun. 2013 Feb;28:49-53. doi: 10.1016/j.bbi.2012.11.009. Epub 2012 Dec 1.

19.

Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view.

Fernandez-Egea E, Garcia-Rizo C, Zimbron J, Kirkpatrick B.

Schizophr Bull. 2013 Mar;39(2):266-7. doi: 10.1093/schbul/sbs134. Epub 2012 Nov 15. No abstract available.

20.

Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.

Strauss GP, Keller WR, Buchanan RW, Gold JM, Fischer BA, McMahon RP, Catalano LT, Culbreth AJ, Carpenter WT, Kirkpatrick B.

Schizophr Res. 2012 Dec;142(1-3):88-92. doi: 10.1016/j.schres.2012.10.012. Epub 2012 Nov 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk